首页 > 最新文献

European review for medical and pharmacological sciences最新文献

英文 中文
Characteristics and predictors of cardiovascular events related to CYP2C19 gene polymorphisms following acute coronary syndrome. 急性冠状动脉综合征后与 CYP2C19 基因多态性相关的心血管事件的特征和预测因素。
IF 3.3 4区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.26355/eurrev_202410_36829
A V Tran, N T K Nguyen, N T N Pham, B L T Tran, A T Huynh, T H Ngo

Objective: Cardiovascular events prognosis based on CYP2C19 gene polymorphisms had many applications in clinical practice. Assessed characteristics and predictive performance of cardiovascular events in acute coronary syndrome patients with CYP2C19 gene polymorphisms.

Patients and methods: The patients were analyzed for CYP2C19 gene polymorphisms by real-time polymerase chain reaction (PCR). The PCR worked with primers around the mutant, as well as two fluorescent probes, one specific for the normal allele and the other for the mutant allele, and cardiovascular events were followed at 3 months and 6 months.

Results: Patients with CYP2C19 gene polymorphism accounted for 48.6% of which CYP2C19 *1/*2 genotype had the highest proportion (31.7%). The normal metabolizer phenotype was the majority (51.4%), and the *1 allele proportion accounted for the most (72.2%). Patients with type 2 diabetes (HR: 3.082, 95% CI: 1.652-5.747, p < 0.001) and ST-segment elevation myocardial infarction (HR: 2.874, 95% CI: 1.528-5.404, p = 0.001) were independent prognostic factors for cardiovascular events at 90 days. Type 2 diabetes was an independent prognostic factor for cardiovascular events at 180 days (HR: 3.714, 95% CI: 1.557-8.862, p = 0.003). The CYP2C19 gene polymorphism was an independent prognostic factor of cardiovascular events at 90 days (HR: 1.965, 95% CI: 1.012-3.814, p = 0.046). However, at 180 days of analysis, the association between the CYP2C19 gene polymorphism was not significant (HR: 2.234, 95% CI: 0.862-5.789, p = 0.098).

Conclusions: CYP2C19 gene polymorphism was an independent prognostic factor of cardiovascular events 90 days after acute coronary syndrome.

目的:基于CYP2C19基因多态性的心血管事件预后在临床实践中有很多应用。评估急性冠脉综合征患者CYP2C19基因多态性的特征和心血管事件的预测能力:通过实时聚合酶链反应(PCR)分析患者的 CYP2C19 基因多态性。PCR使用突变体周围的引物以及两个荧光探针(一个特异于正常等位基因,另一个特异于突变等位基因),并在3个月和6个月时对心血管事件进行随访:CYP2C19基因多态性患者占48.6%,其中CYP2C19 *1/*2基因型比例最高(31.7%)。正常代谢表型占大多数(51.4%),*1等位基因比例最高(72.2%)。2型糖尿病患者(HR:3.082,95% CI:1.652-5.747,p < 0.001)和ST段抬高型心肌梗死患者(HR:2.874,95% CI:1.528-5.404,p = 0.001)是90天后心血管事件的独立预后因素。2型糖尿病是180天后心血管事件的独立预后因素(HR:3.714,95% CI:1.557-8.862,p = 0.003)。CYP2C19 基因多态性是 90 天后心血管事件的独立预后因素(HR:1.965,95% CI:1.012-3.814,p = 0.046)。然而,在180天的分析中,CYP2C19基因多态性之间的关系并不显著(HR:2.234,95% CI:0.862-5.789,P = 0.098):CYP2C19基因多态性是急性冠状动脉综合征90天后心血管事件的独立预后因素。
{"title":"Characteristics and predictors of cardiovascular events related to CYP2C19 gene polymorphisms following acute coronary syndrome.","authors":"A V Tran, N T K Nguyen, N T N Pham, B L T Tran, A T Huynh, T H Ngo","doi":"10.26355/eurrev_202410_36829","DOIUrl":"10.26355/eurrev_202410_36829","url":null,"abstract":"<p><strong>Objective: </strong>Cardiovascular events prognosis based on CYP2C19 gene polymorphisms had many applications in clinical practice. Assessed characteristics and predictive performance of cardiovascular events in acute coronary syndrome patients with CYP2C19 gene polymorphisms.</p><p><strong>Patients and methods: </strong>The patients were analyzed for CYP2C19 gene polymorphisms by real-time polymerase chain reaction (PCR). The PCR worked with primers around the mutant, as well as two fluorescent probes, one specific for the normal allele and the other for the mutant allele, and cardiovascular events were followed at 3 months and 6 months.</p><p><strong>Results: </strong>Patients with CYP2C19 gene polymorphism accounted for 48.6% of which CYP2C19 *1/*2 genotype had the highest proportion (31.7%). The normal metabolizer phenotype was the majority (51.4%), and the *1 allele proportion accounted for the most (72.2%). Patients with type 2 diabetes (HR: 3.082, 95% CI: 1.652-5.747, p < 0.001) and ST-segment elevation myocardial infarction (HR: 2.874, 95% CI: 1.528-5.404, p = 0.001) were independent prognostic factors for cardiovascular events at 90 days. Type 2 diabetes was an independent prognostic factor for cardiovascular events at 180 days (HR: 3.714, 95% CI: 1.557-8.862, p = 0.003). The CYP2C19 gene polymorphism was an independent prognostic factor of cardiovascular events at 90 days (HR: 1.965, 95% CI: 1.012-3.814, p = 0.046). However, at 180 days of analysis, the association between the CYP2C19 gene polymorphism was not significant (HR: 2.234, 95% CI: 0.862-5.789, p = 0.098).</p><p><strong>Conclusions: </strong>CYP2C19 gene polymorphism was an independent prognostic factor of cardiovascular events 90 days after acute coronary syndrome.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 19","pages":"4347-4354"},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142461366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of five-year data of high-risk pregnancies. 评估高危妊娠的五年数据。
IF 3.3 4区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.26355/eurrev_202410_36830
M B Gökçek, H Aslaner

Objective: Pregnancy is a natural physiological process, but certain conditions can increase the risk, leading to high-risk pregnancy. Several risk factors may cause high-risk pregnancy. The leading ones are chronic diseases, anemia, multiple pregnancies, premature rupture of membrane, preeclampsia, obesity, frequent pregnancy, and advanced maternal age.

Patients and methods: A total of 7,230 women with high-risk pregnancies followed up by the Unit of Women's and Reproductive Health of the Directorate of Public Health Services, Kayseri Provincial Directorate of Health between 2016 and 2020 were included in the study. Demographic data, pregnancy outcomes, and risk factors were recorded. The mean age was 27.62±6.55 years. The mean number of pregnancy follow-ups was 3.69±1.36. The mean number of follow-ups for Turkish pregnant women was 3.73±1.34 while it was 1.93±1.1 for foreign pregnant women. Binary logistic regression analysis was used to investigate the effect of risk factors on pregnancy outcomes.

Results: Pregnancies that did not result in live birth were associated with preeclampsia (OR=12.677), hypertension (HT) (OR=2.079), and cardiovascular disorders (OR=2.277). It was revealed that the number of follow-ups for high-risk pregnancies was low.

Conclusions: In conclusion, we believe that increasing monitoring of high-risk pregnancies and developing follow-up models by health authorities will improve the quality of monitoring for high-risk pregnancies.

目的:怀孕是一个自然的生理过程,但某些情况会增加风险,导致高危妊娠。有几种风险因素可能导致高危妊娠。主要包括慢性疾病、贫血、多胎妊娠、胎膜早破、子痫前期、肥胖、频繁妊娠和高龄产妇:本研究共纳入了开塞利省卫生局公共卫生服务局妇女和生殖健康股在 2016 年至 2020 年期间随访的 7230 名高危妊娠妇女。研究记录了人口统计学数据、妊娠结果和风险因素。平均年龄为(27.62±6.55)岁。妊娠随访的平均次数为(3.69±1.36)次。土耳其孕妇的平均随访次数为(3.73±1.34)次,而外国孕妇的平均随访次数为(1.93±1.1)次。采用二元逻辑回归分析法研究风险因素对妊娠结局的影响:结果:没有活产的妊娠与子痫前期(OR=12.677)、高血压(OR=2.079)和心血管疾病(OR=2.277)有关。结果显示,对高危妊娠的随访次数很少:总之,我们认为,卫生部门加强对高危妊娠的监测并制定随访模式将提高对高危妊娠的监测质量。
{"title":"Assessment of five-year data of high-risk pregnancies.","authors":"M B Gökçek, H Aslaner","doi":"10.26355/eurrev_202410_36830","DOIUrl":"10.26355/eurrev_202410_36830","url":null,"abstract":"<p><strong>Objective: </strong>Pregnancy is a natural physiological process, but certain conditions can increase the risk, leading to high-risk pregnancy. Several risk factors may cause high-risk pregnancy. The leading ones are chronic diseases, anemia, multiple pregnancies, premature rupture of membrane, preeclampsia, obesity, frequent pregnancy, and advanced maternal age.</p><p><strong>Patients and methods: </strong>A total of 7,230 women with high-risk pregnancies followed up by the Unit of Women's and Reproductive Health of the Directorate of Public Health Services, Kayseri Provincial Directorate of Health between 2016 and 2020 were included in the study. Demographic data, pregnancy outcomes, and risk factors were recorded. The mean age was 27.62±6.55 years. The mean number of pregnancy follow-ups was 3.69±1.36. The mean number of follow-ups for Turkish pregnant women was 3.73±1.34 while it was 1.93±1.1 for foreign pregnant women. Binary logistic regression analysis was used to investigate the effect of risk factors on pregnancy outcomes.</p><p><strong>Results: </strong>Pregnancies that did not result in live birth were associated with preeclampsia (OR=12.677), hypertension (HT) (OR=2.079), and cardiovascular disorders (OR=2.277). It was revealed that the number of follow-ups for high-risk pregnancies was low.</p><p><strong>Conclusions: </strong>In conclusion, we believe that increasing monitoring of high-risk pregnancies and developing follow-up models by health authorities will improve the quality of monitoring for high-risk pregnancies.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 19","pages":"4355-4365"},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142461365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of formic acid in combination with cDMARDs in rheumatoid arthritis. 甲酸与 cDMARDs 联用对类风湿性关节炎的疗效。
IF 3.3 4区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.26355/eurrev_202410_36831
T-T Cao, J-L Ma, Y Zhang, J-W Peng, H Lin

Objective: The immune system of the body mistakenly targets its own joints in rheumatoid arthritis (RA), a chronic autoimmune disease that causes pain, inflammation, and damage. The complexity of RA often requires the simultaneous use of several different management strategies. This study examines the potential enhancement of conventional RA treatments, specifically conventional Disease-Modifying Anti-Rheumatic Drugs (cDMARDs), by the addition of formic acid, a naturally occurring substance that may possess anti-inflammatory properties.

Patients and methods: A total of 90 children diagnosed with rheumatoid arthritis were examined at our hospital from 2020 to 2022. We segregated them into two cohorts, each consisting of 45 children. One cohort was administered conventional rheumatoid arthritis (RA) treatments, referred to as cDMARDs, which specifically included methotrexate and leflunomide. The other group was administered the standard treatments in addition to a low dosage of a specialized medication known as all-trans retinoic acid. We conducted follow-up assessments on the children at 6 months and 1-year post-treatment. We sought to evaluate the efficacy of the treatments by assessing the subjective reports of the children and their physicians, analyzing the outcomes of medical examinations, and examining diagnostic images, such as X-rays. Furthermore, we took measures to ensure the safety of the treatments.

Results: Among the cohort exclusively administered cDMARDs, approximately 26.7% exhibited significant improvement, 24.4% demonstrated moderate improvement, and 6.7% displayed minor improvement after a duration of 6 months. Approximately 57.8% of the children in this group experienced positive outcomes as a result of the treatment. The group that received retinoic acid also demonstrated superior outcomes. Approximately one-third (33.3%) of the participants demonstrated significant improvement, while another one-third showed moderate improvement. Additionally, 11.1% of the participants displayed minor improvement after a period of six months. Upon comparing the two groups, it was observed that the group receiving retinoic acid demonstrated a significantly superior outcome (p<0.05).

Conclusions: Overall, the incorporation of all-trans retinoic acid alongside conventional treatments for children with RA appears to enhance their efficacy.

目的:类风湿性关节炎(RA)是一种慢性自身免疫性疾病,会引起疼痛、炎症和损伤,人体的免疫系统会错误地以自身关节为目标。由于类风湿性关节炎的复杂性,通常需要同时使用几种不同的治疗策略。本研究探讨了通过添加甲酸(一种可能具有抗炎特性的天然物质)来增强常规RA治疗方法(特别是常规疾病修饰抗风湿药(cDMARDs))的可能性:2020年至2022年,我院共对90名确诊为类风湿性关节炎的儿童进行了检查。我们将他们分为两组,每组 45 名儿童。一组接受常规类风湿性关节炎(RA)治疗,即 cDMARDs,具体包括甲氨蝶呤和来氟米特。另一组患儿在接受标准治疗的同时,还服用了一种名为全反式维甲酸的低剂量特效药。我们在治疗后 6 个月和 1 年对患儿进行了随访评估。我们试图通过评估患儿及其医生的主观报告、分析体检结果以及检查诊断图像(如 X 光片)来评估治疗效果。此外,我们还采取措施确保治疗的安全性:结果:在完全使用 cDMARDs 的组群中,约 26.7% 的患儿在 6 个月后病情明显好转,24.4% 的患儿病情中度好转,6.7% 的患儿病情轻微好转。该组中约有 57.8% 的儿童在接受治疗后取得了积极的疗效。接受维甲酸治疗的小组也取得了较好的疗效。约有三分之一(33.3%)的参试者的病情有明显改善,另有三分之一的参试者的病情有中度改善。此外,11.1% 的参与者在 6 个月后有轻微改善。在对两组进行比较后发现,接受维甲酸治疗组的疗效显著优于接受维甲酸治疗组(P结论:总的来说,在对患有RA的儿童进行常规治疗的同时使用全反式维甲酸似乎能提高疗效。
{"title":"Efficacy of formic acid in combination with cDMARDs in rheumatoid arthritis.","authors":"T-T Cao, J-L Ma, Y Zhang, J-W Peng, H Lin","doi":"10.26355/eurrev_202410_36831","DOIUrl":"10.26355/eurrev_202410_36831","url":null,"abstract":"<p><strong>Objective: </strong>The immune system of the body mistakenly targets its own joints in rheumatoid arthritis (RA), a chronic autoimmune disease that causes pain, inflammation, and damage. The complexity of RA often requires the simultaneous use of several different management strategies. This study examines the potential enhancement of conventional RA treatments, specifically conventional Disease-Modifying Anti-Rheumatic Drugs (cDMARDs), by the addition of formic acid, a naturally occurring substance that may possess anti-inflammatory properties.</p><p><strong>Patients and methods: </strong>A total of 90 children diagnosed with rheumatoid arthritis were examined at our hospital from 2020 to 2022. We segregated them into two cohorts, each consisting of 45 children. One cohort was administered conventional rheumatoid arthritis (RA) treatments, referred to as cDMARDs, which specifically included methotrexate and leflunomide. The other group was administered the standard treatments in addition to a low dosage of a specialized medication known as all-trans retinoic acid. We conducted follow-up assessments on the children at 6 months and 1-year post-treatment. We sought to evaluate the efficacy of the treatments by assessing the subjective reports of the children and their physicians, analyzing the outcomes of medical examinations, and examining diagnostic images, such as X-rays. Furthermore, we took measures to ensure the safety of the treatments.</p><p><strong>Results: </strong>Among the cohort exclusively administered cDMARDs, approximately 26.7% exhibited significant improvement, 24.4% demonstrated moderate improvement, and 6.7% displayed minor improvement after a duration of 6 months. Approximately 57.8% of the children in this group experienced positive outcomes as a result of the treatment. The group that received retinoic acid also demonstrated superior outcomes. Approximately one-third (33.3%) of the participants demonstrated significant improvement, while another one-third showed moderate improvement. Additionally, 11.1% of the participants displayed minor improvement after a period of six months. Upon comparing the two groups, it was observed that the group receiving retinoic acid demonstrated a significantly superior outcome (p<0.05).</p><p><strong>Conclusions: </strong>Overall, the incorporation of all-trans retinoic acid alongside conventional treatments for children with RA appears to enhance their efficacy.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 19","pages":"4366-4375"},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142461368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A double communication branch between musculocutaneous and median nerves: first case report, anatomical study, and comprehensive review of clinical implications. 肌皮神经和正中神经之间的双沟通分支:首例病例报告、解剖学研究和临床意义综合评述。
IF 3.3 4区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.26355/eurrev_202410_36833
C Fumo, L Marzella, A Lazzerini, F De Francesco, R De Vitis

Background: According to the literature, the brachial plexus presents a high rate of anatomical variations in the human neural system. The musculocutaneous nerve, a vital component of the brachial plexus, exhibits significant anatomical variations that hold clinical relevance across multiple medical disciplines. This case report, with a comprehensive review, explores the different variations in the course, branching patterns, and clinical implications of the musculocutaneous nerve. Understanding these variations is essential for surgeons, radiologists, and clinicians to enhance surgical precision, improve diagnostic accuracy, and reduce the risk of iatrogenic complications.

Case report: During an anatomical dissection we observed a very rare anatomical variation of the musculocutaneous nerve. Based on this discovery, we performed research in the literature with the aim of finding if this variation has been previously described. Firstly, we identified various classifications of anatomical variations of communicating branches between the musculocutaneous and median nerves, and then we observed that these variations corresponded to various rates of frequency. Our finding is a rare undescribed anatomical variant within the variants classified as Type II according to Le Minor, which is observed in 6.8-10.7% of cases.

Conclusions: The peculiar position of anatomical variations and anastomosis has clinical and functional relevance. Healthcare professionals must be aware of these variations to minimize surgical complications, accurately diagnose neurovascular pathologies, and optimize patient management. Further research into the genetic and embryological underpinnings of these variations may provide additional insights into this intriguing aspect of human anatomy.

背景:根据文献记载,臂丛神经在人体神经系统中的解剖变异率很高。肌皮神经是臂丛神经的重要组成部分,在解剖学上表现出显著的变异,在多个医学学科中都具有临床意义。本病例报告通过全面回顾,探讨了肌皮神经在走向、分支模式和临床影响方面的不同变化。了解这些变异对于外科医生、放射科医生和临床医生提高手术精确度、提高诊断准确性和降低先天性并发症风险至关重要:病例报告:在一次解剖过程中,我们观察到了一种非常罕见的肌皮神经解剖变异。基于这一发现,我们对文献进行了研究,目的是找出以前是否有描述过这种变异。首先,我们确定了肌皮神经和正中神经之间沟通分支解剖变异的各种分类,然后观察到这些变异对应不同的频率。我们的发现是一种罕见的未被描述的解剖变异,根据 Le Minor 的分类,这种变异属于 II 型,在 6.8%-10.7%的病例中可以观察到:结论:解剖变异和吻合口的特殊位置与临床和功能相关。医护人员必须了解这些变异,以尽量减少手术并发症,准确诊断神经血管病变,优化患者管理。对这些变异的遗传学和胚胎学基础的进一步研究可能会对人体解剖学的这一有趣方面提供更多的见解。
{"title":"A double communication branch between musculocutaneous and median nerves: first case report, anatomical study, and comprehensive review of clinical implications.","authors":"C Fumo, L Marzella, A Lazzerini, F De Francesco, R De Vitis","doi":"10.26355/eurrev_202410_36833","DOIUrl":"10.26355/eurrev_202410_36833","url":null,"abstract":"<p><strong>Background: </strong>According to the literature, the brachial plexus presents a high rate of anatomical variations in the human neural system. The musculocutaneous nerve, a vital component of the brachial plexus, exhibits significant anatomical variations that hold clinical relevance across multiple medical disciplines. This case report, with a comprehensive review, explores the different variations in the course, branching patterns, and clinical implications of the musculocutaneous nerve. Understanding these variations is essential for surgeons, radiologists, and clinicians to enhance surgical precision, improve diagnostic accuracy, and reduce the risk of iatrogenic complications.</p><p><strong>Case report: </strong>During an anatomical dissection we observed a very rare anatomical variation of the musculocutaneous nerve. Based on this discovery, we performed research in the literature with the aim of finding if this variation has been previously described. Firstly, we identified various classifications of anatomical variations of communicating branches between the musculocutaneous and median nerves, and then we observed that these variations corresponded to various rates of frequency. Our finding is a rare undescribed anatomical variant within the variants classified as Type II according to Le Minor, which is observed in 6.8-10.7% of cases.</p><p><strong>Conclusions: </strong>The peculiar position of anatomical variations and anastomosis has clinical and functional relevance. Healthcare professionals must be aware of these variations to minimize surgical complications, accurately diagnose neurovascular pathologies, and optimize patient management. Further research into the genetic and embryological underpinnings of these variations may provide additional insights into this intriguing aspect of human anatomy.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 19","pages":"4376-4382"},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142461364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of radiofrequency electromagnetic radiation emitted by mobile phones on rat parotid gland histology - an experimental study. 移动电话发射的射频电磁辐射对大鼠腮腺组织学的影响--一项实验研究。
IF 3.3 4区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.26355/eurrev_202410_36864
L I Matei, M A Neag, L P Mocan, R T Suflețel, A Cuțaș, M M Onofrei, L M Gherman, G Armencea, C Mihu, A Ilea, C M Mihu, I R Bordea, F Inchingolo, G Dipalma, C S Melincovici

Objective: The advancement of telecommunication technology and devices promptly transformed mobile phones into indispensable objects in our day-to-day lives, but their biological effects remain unclear. Therefore, this study aimed to investigate the potential histopathological changes induced by mobile phone radiation in the parotid gland and the nearby tissues.

Materials and methods: Thirty female Rattus Norvegicus rats were divided into three groups: group 1 (exposed for 30 days), group 2 (exposed for 60 days), and control group (non-exposed). Each subject was exposed to mobile phone radiation in the form of a phone call for two hours every day for their subsequent exposure time. The exposure was always directed towards the same side of the face throughout the whole exposure period. At the end of the exposure period, a comprehensive examination was conducted, including inspection of the orofacial structures, tissue sections of the parotid glands, overlying skin, oral mucosa, and cervical lymph nodes, as well as obtaining smears from the oral cavity. To highlight the presence of micronuclei within the exfoliated squamous cells of the oral epithelium, Feulgen stain was performed.

Results: The results showed a significant activation of the fibroblasts in the parotid gland septa, in both exposed experimental groups, compared to the control group. We also detected significant cervical lymph node reactive changes, hyperkeratosis of the oral epithelium, and activated fibroblasts in the dermis and oral mucosa lamina propria in both experimental groups. Dermal fibrosis and lamina propria fibrosis were significantly increased in the second experimental group, compared to the control group. Moreover, vascular congestion in the parotid gland, dermal, and lamina propria fibrosis were significantly increased in the second study group compared to the first one.

Conclusions: These findings suggest that exposure to mobile phone radiation may lead to pathological changes in the parotid gland and nearby tissues of experimental rats.

研究目的电信技术和设备的进步使手机迅速成为我们日常生活中不可或缺的物品,但其生物效应仍不明确。因此,本研究旨在探讨手机辐射对腮腺及其附近组织可能引起的组织病理学变化:将 30 只雌性大鼠分为三组:第一组(暴露 30 天)、第二组(暴露 60 天)和对照组(未暴露)。在随后的暴露时间内,每个受试者每天都会受到两小时的手机辐射,形式为通话。在整个暴露期间,手机辐射始终照射面部的同一侧。暴露期结束后,进行全面检查,包括检查口面部结构、腮腺组织切片、上覆皮肤、口腔黏膜和颈淋巴结,以及从口腔采集涂片。为了凸显口腔上皮脱落鳞状细胞中存在的微核,进行了费尔根染色:结果表明,与对照组相比,两组暴露实验中腮腺隔膜的成纤维细胞都明显活化。我们还在两个实验组中发现了明显的颈淋巴结反应性变化、口腔上皮角化过度以及真皮和口腔粘膜固有层中的成纤维细胞活化。与对照组相比,第二实验组的真皮纤维化和固有膜纤维化明显加重。此外,与对照组相比,第二实验组腮腺血管充血、真皮和固有膜纤维化程度明显加重:这些研究结果表明,暴露于手机辐射可能会导致实验鼠腮腺及其附近组织发生病理变化。
{"title":"The effects of radiofrequency electromagnetic radiation emitted by mobile phones on rat parotid gland histology - an experimental study.","authors":"L I Matei, M A Neag, L P Mocan, R T Suflețel, A Cuțaș, M M Onofrei, L M Gherman, G Armencea, C Mihu, A Ilea, C M Mihu, I R Bordea, F Inchingolo, G Dipalma, C S Melincovici","doi":"10.26355/eurrev_202410_36864","DOIUrl":"https://doi.org/10.26355/eurrev_202410_36864","url":null,"abstract":"<p><strong>Objective: </strong>The advancement of telecommunication technology and devices promptly transformed mobile phones into indispensable objects in our day-to-day lives, but their biological effects remain unclear. Therefore, this study aimed to investigate the potential histopathological changes induced by mobile phone radiation in the parotid gland and the nearby tissues.</p><p><strong>Materials and methods: </strong>Thirty female Rattus Norvegicus rats were divided into three groups: group 1 (exposed for 30 days), group 2 (exposed for 60 days), and control group (non-exposed). Each subject was exposed to mobile phone radiation in the form of a phone call for two hours every day for their subsequent exposure time. The exposure was always directed towards the same side of the face throughout the whole exposure period. At the end of the exposure period, a comprehensive examination was conducted, including inspection of the orofacial structures, tissue sections of the parotid glands, overlying skin, oral mucosa, and cervical lymph nodes, as well as obtaining smears from the oral cavity. To highlight the presence of micronuclei within the exfoliated squamous cells of the oral epithelium, Feulgen stain was performed.</p><p><strong>Results: </strong>The results showed a significant activation of the fibroblasts in the parotid gland septa, in both exposed experimental groups, compared to the control group. We also detected significant cervical lymph node reactive changes, hyperkeratosis of the oral epithelium, and activated fibroblasts in the dermis and oral mucosa lamina propria in both experimental groups. Dermal fibrosis and lamina propria fibrosis were significantly increased in the second experimental group, compared to the control group. Moreover, vascular congestion in the parotid gland, dermal, and lamina propria fibrosis were significantly increased in the second study group compared to the first one.</p><p><strong>Conclusions: </strong>These findings suggest that exposure to mobile phone radiation may lead to pathological changes in the parotid gland and nearby tissues of experimental rats.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 20","pages":"4405-4419"},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction Note: MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2. 撤稿说明:MicroRNA-613 通过靶向 FRS2 抑制 Wilms 肿瘤的增殖、迁移和侵袭。
IF 3.3 4区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.26355/eurrev_202410_36857
H-F Wang, Y-Y Zhang, H-W Zhuang, M Xu

The article "MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2" by H.-F. Wang, Y.-Y. Zhang, H.-W. Zhuang, M. Xu, published in Eur Rev Med Pharmacol Sci 2017; 21 (15): 3360-3369 - PMID: 28829507 has been retracted by the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/19E8759FF9D86F9AB839B4FCE08C62), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The authors have been informed about the journal's investigation but remained unresponsive and have not provided the study's raw data. The journal's investigation identified numerous duplications within Figure 2, as well as duplications between Figure 2 and figures from previously published articles (https://doi.org/10.1111/cas.12656, https://doi.org/10.1016/j.biochi.2019.03.011). Duplications were also found within Figure 3 and between Figure 3 and previously published articles (doi: 10.12659/msm.921288, doi: 10.12659/msm.903462). Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/13201.

文章 "MicroRNA-613通过靶向FRS2抑制Wilms'肿瘤的增殖、迁移和侵袭 "由H.-F. Wang, Y -Y.发表。Wang, Y.-Y. Zhang, H.-W.Zhang, H.-W.Zhuang, M. Xu, 发表于 Eur Rev Med Pharmacol Sci 2017; 21 (15):3360-3369 - PMID: 28829507 已被主编撤回。在PubPeer(链接:https://pubpeer.com/publications/19E8759FF9D86F9AB839B4FCE08C62)上提出了一些问题后,主编已开始调查,以评估结果的有效性以及可能存在的数字篡改。本刊已向作者通报了调查情况,但作者仍未做出回应,也未提供研究的原始数据。该期刊的调查发现图2中有大量重复,图2与之前发表的文章(https://doi.org/10.1111/cas.12656, https://doi.org/10.1016/j.biochi.2019.03.011)中的图表也有重复。在图 3 中以及图 3 与之前发表的文章(doi: 10.12659/msm.921288,doi: 10.12659/msm.903462)之间也发现了重复。因此,主编不信任所提供的结果,决定撤回这篇文章。本文已被撤回。https://www.europeanreview.org/article/13201。
{"title":"Retraction Note: MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2.","authors":"H-F Wang, Y-Y Zhang, H-W Zhuang, M Xu","doi":"10.26355/eurrev_202410_36857","DOIUrl":"https://doi.org/10.26355/eurrev_202410_36857","url":null,"abstract":"<p><p>The article \"MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2\" by H.-F. Wang, Y.-Y. Zhang, H.-W. Zhuang, M. Xu, published in Eur Rev Med Pharmacol Sci 2017; 21 (15): 3360-3369 - PMID: 28829507 has been retracted by the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/19E8759FF9D86F9AB839B4FCE08C62), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The authors have been informed about the journal's investigation but remained unresponsive and have not provided the study's raw data. The journal's investigation identified numerous duplications within Figure 2, as well as duplications between Figure 2 and figures from previously published articles (https://doi.org/10.1111/cas.12656, https://doi.org/10.1016/j.biochi.2019.03.011). Duplications were also found within Figure 3 and between Figure 3 and previously published articles (doi: 10.12659/msm.921288, doi: 10.12659/msm.903462). Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/13201.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 20","pages":"4402"},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical profile and short-term outcomes of acute severe ulcerative colitis in Vietnam: insights from a resource-limited setting. 越南急性重度溃疡性结肠炎的临床概况和短期疗效:来自资源有限地区的启示。
IF 3.3 4区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.26355/eurrev_202410_36827
L M Dang, T H Dinh, T M Huynh, C D Nguyen, T T T Trinh, H H Bui

Objective: Acute severe ulcerative colitis (ASUC) is a significant complication of ulcerative colitis, affecting roughly 25% of patients and increasing the risk of colectomy and hospital mortality. While intravenous steroids are a primary treatment, only 67% of patients respond, necessitating rescue therapy for non-responders. Data on ASUC in the Vietnamese population are scarce. This study aims to provide insights into the clinical characteristics and short-term outcomes of Vietnamese patients with ASUC.

Patients and methods: We conducted a prospective case series on ASUC patients admitted to the University Medical Center in Ho Chi Minh City from January 2021 to June 2023. Steroid response was assessed using the Travis Oxford criteria. We evaluated clinical features, in-hospital steroid response rates, endoscopic remission, and colectomy rates 12 months post-hospitalization.

Results: Seventeen patients with a median age of 42 years (70.6% male) were included. The median time from symptom onset to diagnosis was six weeks, and 47.1% had a history of ulcerative colitis. Median CRP value was 75.8 mg/L, and 76.5% had fecal calprotectin concentrations above 800 µg/g. All patients had a Mayo endoscopic subscore of ≥2, with 12.5% showing deep ulcers. Eleven patients (64.7%) responded to in-hospital steroid treatment, while 6 (35.3%) required rescue therapy with infliximab or tofacitinib. After one year, 10 of 11 (90.1%) achieved mucosal healing, and no patients underwent colectomy.

Conclusions: Corticosteroids remain the cornerstone for initial ASUC therapy, though many patients do not respond. Anti-TNF agents and tofacitinib show potential benefits for those unresponsive to steroids. This study highlights the effectiveness of corticosteroids and biologics in managing ASUC in Vietnam.

目的:急性重度溃疡性结肠炎(ASUC)是溃疡性结肠炎的一种重要并发症,约有 25% 的患者会受到影响,并增加结肠切除术和住院死亡率的风险。虽然静脉注射类固醇是一种主要治疗方法,但只有 67% 的患者对此有反应,因此必须对无反应者进行抢救治疗。有关越南人群 ASUC 的数据很少。本研究旨在深入了解越南 ASUC 患者的临床特征和短期疗效:我们对 2021 年 1 月至 2023 年 6 月期间胡志明市大学医疗中心收治的 ASUC 患者进行了前瞻性病例系列研究。使用特拉维斯-牛津标准评估类固醇反应。我们评估了临床特征、院内类固醇反应率、内镜缓解率和住院后 12 个月的结肠切除率:共纳入 17 名患者,中位年龄为 42 岁(70.6% 为男性)。从症状出现到确诊的中位时间为六周,47.1%的患者有溃疡性结肠炎病史。CRP 中位值为 75.8 mg/L,76.5% 的患者粪便钙蛋白浓度超过 800 µg/g。所有患者的梅奥内镜评分均≥2,12.5%的患者有深度溃疡。11名患者(64.7%)对院内类固醇治疗有反应,6名患者(35.3%)需要使用英夫利昔单抗或托法替尼进行抢救治疗。一年后,11名患者中有10名(90.1%)的粘膜愈合,没有患者接受结肠切除术:结论:皮质类固醇仍是ASUC初始治疗的基石,尽管许多患者并无反应。抗肿瘤坏死因子药物和托法替尼对类固醇治疗无效的患者有潜在疗效。这项研究强调了皮质类固醇和生物制剂在越南治疗 ASUC 的有效性。
{"title":"Clinical profile and short-term outcomes of acute severe ulcerative colitis in Vietnam: insights from a resource-limited setting.","authors":"L M Dang, T H Dinh, T M Huynh, C D Nguyen, T T T Trinh, H H Bui","doi":"10.26355/eurrev_202410_36827","DOIUrl":"10.26355/eurrev_202410_36827","url":null,"abstract":"<p><strong>Objective: </strong>Acute severe ulcerative colitis (ASUC) is a significant complication of ulcerative colitis, affecting roughly 25% of patients and increasing the risk of colectomy and hospital mortality. While intravenous steroids are a primary treatment, only 67% of patients respond, necessitating rescue therapy for non-responders. Data on ASUC in the Vietnamese population are scarce. This study aims to provide insights into the clinical characteristics and short-term outcomes of Vietnamese patients with ASUC.</p><p><strong>Patients and methods: </strong>We conducted a prospective case series on ASUC patients admitted to the University Medical Center in Ho Chi Minh City from January 2021 to June 2023. Steroid response was assessed using the Travis Oxford criteria. We evaluated clinical features, in-hospital steroid response rates, endoscopic remission, and colectomy rates 12 months post-hospitalization.</p><p><strong>Results: </strong>Seventeen patients with a median age of 42 years (70.6% male) were included. The median time from symptom onset to diagnosis was six weeks, and 47.1% had a history of ulcerative colitis. Median CRP value was 75.8 mg/L, and 76.5% had fecal calprotectin concentrations above 800 µg/g. All patients had a Mayo endoscopic subscore of ≥2, with 12.5% showing deep ulcers. Eleven patients (64.7%) responded to in-hospital steroid treatment, while 6 (35.3%) required rescue therapy with infliximab or tofacitinib. After one year, 10 of 11 (90.1%) achieved mucosal healing, and no patients underwent colectomy.</p><p><strong>Conclusions: </strong>Corticosteroids remain the cornerstone for initial ASUC therapy, though many patients do not respond. Anti-TNF agents and tofacitinib show potential benefits for those unresponsive to steroids. This study highlights the effectiveness of corticosteroids and biologics in managing ASUC in Vietnam.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 19","pages":"4328-4338"},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142461367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Correction: Evaluation of Potential Drug-Drug Interactions in the Intensive Care Unit. 作者更正:重症监护室潜在药物相互作用的评估。
IF 3.3 4区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.26355/eurrev_202410_36861
M S Dagdelen, D Gulen, I Ceylan, N K Girgin

Correction to: Eur Rev Med Pharmacol Sci 2021; 25 (18): 5801-5806-DOI: 10.26355/eurrev_202109_26798-PMID: 34604971 published online on September 30, 2021. The methodology section of this research article incorrectly stated that the lexi-interact checker program is freely accessible. The study was conducted at Uludağ University using university-access computers. As a result, the lexi-interact program, provided through UpToDate and accessed via the university's subscription service, was mistakenly described as a free resource. Therefore, the sentence "pDDIs, defined using the lexi-interact (a free online interaction checker, provided from UpToDate, 2020, https://www.uptodate.com/drug-interactions), were classified based on the significance of the interaction level (minor, moderate, major)" has been corrected as follows: - pDDIs, defined using the lexi-interact (an online interaction checker, provided from UpToDate, 2020, https://www.uptodate.com/drug-interactions), were classified based on the significance of the interaction level (minor, moderate, major). There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/26798.

Correction to:Eur Rev Med Pharmacol Sci 2021; 25 (18):5801-5806-DOI: 10.26355/eurrev_202109_26798-PMID: 34604971 于 2021 年 9 月 30 日在线发表。本研究文章的方法论部分错误地指出,lexi-interact 检查程序可以免费获取。本研究是在乌鲁达大学使用学校提供的计算机进行的。因此,通过 UpToDate 提供并通过大学订阅服务访问的 lexii-interact 程序被错误地描述为免费资源。因此,"使用lexi-interact(UpToDate提供的免费在线交互作用检查程序,2020年,https://www.uptodate.com/drug-interactions)定义的pDDIs,根据交互作用的重要程度(轻微、中等、严重)进行分类 "这句话更正如下:- 使用lexi-interact(在线交互作用检查器,由UpToDate, 2020, https://www.uptodate.com/drug-interactions提供)定义的pDDIs根据交互作用的显著程度(轻微、中等、严重)进行分类。本文有一些修改。https://www.europeanreview.org/article/26798。
{"title":"Author Correction: Evaluation of Potential Drug-Drug Interactions in the Intensive Care Unit.","authors":"M S Dagdelen, D Gulen, I Ceylan, N K Girgin","doi":"10.26355/eurrev_202410_36861","DOIUrl":"https://doi.org/10.26355/eurrev_202410_36861","url":null,"abstract":"<p><p>Correction to: Eur Rev Med Pharmacol Sci 2021; 25 (18): 5801-5806-DOI: 10.26355/eurrev_202109_26798-PMID: 34604971 published online on September 30, 2021. The methodology section of this research article incorrectly stated that the lexi-interact checker program is freely accessible. The study was conducted at Uludağ University using university-access computers. As a result, the lexi-interact program, provided through UpToDate and accessed via the university's subscription service, was mistakenly described as a free resource. Therefore, the sentence \"pDDIs, defined using the lexi-interact (a free online interaction checker, provided from UpToDate, 2020, https://www.uptodate.com/drug-interactions), were classified based on the significance of the interaction level (minor, moderate, major)\" has been corrected as follows: - pDDIs, defined using the lexi-interact (an online interaction checker, provided from UpToDate, 2020, https://www.uptodate.com/drug-interactions), were classified based on the significance of the interaction level (minor, moderate, major). There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/26798.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 20","pages":"4404"},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GnRH antagonist protocol with hCG triggering ameliorates fertilization defect caused by failure of cumulus cell pentraxin-3 expression in unilateral endometriomas. GnRH 拮抗剂与 hCG 触发方案可改善单侧子宫内膜异位症中因积液细胞 pentraxin-3 表达失败而导致的受精缺陷。
IF 3.3 4区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.26355/eurrev_202410_36869
N D Gungor, O Celik, A Ersahin, N Celik, M Kobaner, M Yardim, S Dalkilic, S Melil, K Cil, S Celik, R Akkoc

Objective: The aim of the study was to determine the expression pattern of long pentraxin 3 (PTX3) mRNA in cumulus cells (CCs) isolated from metaphase II oocytes of women with unilateral endometrioma undergoing controlled ovarian stimulation using a gonadotropin-releasing hormone antagonist (GnRHa) protocol.

Patients and methods: A total of 60 CC samples, 30 from the affected ovary and 30 from the contralateral ovary, were collected from 12 patients with unilateral endometrioma who underwent flexible GnRHa protocol with recombinant human chorionic gonadotropin (rhCG) trigger. Thirty CC samples collected from the left ovary of 12 women with male factor infertility were used as external controls. Long PTX3 mRNA expression in each group was analyzed by real-time polymerase chain reaction (RT-PCR). Relative gene expression (fold-change) was calculated according to the 2-ΔΔCt equation. Fertilization rates after intracytoplasmic sperm injection (ICSI) were recorded for each group.

Results: CC-PTX3 mRNA expression in the unilateral endometrioma group was significantly lower than the mRNA expression of the disease-free ovary (0.90±0.01 vs. 0.25±0.02, p<0.01). CC-PTX3 mRNA expression of MII oocytes of the disease-free ovary was found to be similar to the control group (1.02±0.03 vs. 0.90±0.01, p=0.107). A significant 3.6-fold downregulation was observed in the CC-PTX3 mRNA expression of the endometrioma group compared to the CC-PTX3 mRNA expression in the contralateral ovary. CC-PTX3 mRNA expression in the endometrioma group was downregulated 4.08-fold compared to the CC-PTX3 mRNA expression of the control group (1.02±0.03 vs. 0.25±0.02, p<0.001). The cumulus morphologies of the endometrioma group with low CC-PTX3 expression and the groups with normal CC-PTX3 levels were similar. Fertilization rates of the endometrioma group were similar to the contralateral ovary and control groups.

Conclusions: Unilateral endometrioma reduces CC-PTX3 expression but does not affect disease-free ovaries. The GnRHa protocol improved the fertilization rates, suggesting that failed CC-PTX3 expression is an in vivo pathology.

研究目的该研究旨在确定长五肽酶3(PTX3)mRNA在从单侧子宫内膜异位症妇女卵母细胞分裂期Ⅱ卵母细胞分离的积层细胞(CCs)中的表达模式,该妇女接受了使用促性腺激素释放激素拮抗剂(GnRHa)方案的控制性卵巢刺激:12 名单侧子宫内膜异位症患者接受了重组人绒毛膜促性腺激素(rhCG)触发的灵活 GnRHa 方案,共收集了 60 份 CC 样本,其中 30 份来自受影响的卵巢,30 份来自对侧卵巢。从 12 名男性因素不孕妇女的左侧卵巢采集的 30 份 CC 样本作为外部对照。通过实时聚合酶链反应(RT-PCR)分析各组长 PTX3 mRNA 的表达。根据 2-ΔΔCt 公式计算相对基因表达量(fold-change)。记录各组卵胞浆内单精子显微注射(ICSI)后的受精率:结果:单侧子宫内膜异位症组的 CC-PTX3 mRNA 表达量明显低于无病卵巢的 mRNA 表达量(0.90±0.01 vs. 0.25±0.02,p):单侧子宫内膜瘤会降低CC-PTX3的表达,但不会影响无病卵巢。GnRHa方案提高了受精率,表明CC-PTX3表达失败是一种体内病理现象。
{"title":"GnRH antagonist protocol with hCG triggering ameliorates fertilization defect caused by failure of cumulus cell pentraxin-3 expression in unilateral endometriomas.","authors":"N D Gungor, O Celik, A Ersahin, N Celik, M Kobaner, M Yardim, S Dalkilic, S Melil, K Cil, S Celik, R Akkoc","doi":"10.26355/eurrev_202410_36869","DOIUrl":"https://doi.org/10.26355/eurrev_202410_36869","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the study was to determine the expression pattern of long pentraxin 3 (PTX3) mRNA in cumulus cells (CCs) isolated from metaphase II oocytes of women with unilateral endometrioma undergoing controlled ovarian stimulation using a gonadotropin-releasing hormone antagonist (GnRHa) protocol.</p><p><strong>Patients and methods: </strong>A total of 60 CC samples, 30 from the affected ovary and 30 from the contralateral ovary, were collected from 12 patients with unilateral endometrioma who underwent flexible GnRHa protocol with recombinant human chorionic gonadotropin (rhCG) trigger. Thirty CC samples collected from the left ovary of 12 women with male factor infertility were used as external controls. Long PTX3 mRNA expression in each group was analyzed by real-time polymerase chain reaction (RT-PCR). Relative gene expression (fold-change) was calculated according to the 2-ΔΔCt equation. Fertilization rates after intracytoplasmic sperm injection (ICSI) were recorded for each group.</p><p><strong>Results: </strong>CC-PTX3 mRNA expression in the unilateral endometrioma group was significantly lower than the mRNA expression of the disease-free ovary (0.90±0.01 vs. 0.25±0.02, p<0.01). CC-PTX3 mRNA expression of MII oocytes of the disease-free ovary was found to be similar to the control group (1.02±0.03 vs. 0.90±0.01, p=0.107). A significant 3.6-fold downregulation was observed in the CC-PTX3 mRNA expression of the endometrioma group compared to the CC-PTX3 mRNA expression in the contralateral ovary. CC-PTX3 mRNA expression in the endometrioma group was downregulated 4.08-fold compared to the CC-PTX3 mRNA expression of the control group (1.02±0.03 vs. 0.25±0.02, p<0.001). The cumulus morphologies of the endometrioma group with low CC-PTX3 expression and the groups with normal CC-PTX3 levels were similar. Fertilization rates of the endometrioma group were similar to the contralateral ovary and control groups.</p><p><strong>Conclusions: </strong>Unilateral endometrioma reduces CC-PTX3 expression but does not affect disease-free ovaries. The GnRHa protocol improved the fertilization rates, suggesting that failed CC-PTX3 expression is an in vivo pathology.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 20","pages":"4461-4468"},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction Note: The inhibitory effect of miR-375 targeting sp1 in colorectal cancer cell proliferation. 撤稿说明:靶向 sp1 的 miR-375 对结直肠癌细胞增殖的抑制作用。
IF 3.3 4区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.26355/eurrev_202410_36859
X-H Liu, J Wang, Y-H Dong

The article "The inhibitory effect of miR-375 targeting sp1 in colorectal cancer cell proliferation" by X.-H. Liu, J. Wang, Y.-H. Dong, published in Eur Rev Med Pharmacol Sci 2018; 22 (2): 405-411 - PMID: 29424897 has been retracted by the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/DF4072237DD0F624A7AE9B34B4EB6D), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. Initially, the authors asked to retract this manuscript, but were not available for further comments during the investigation; therefore, raw data were not provided. The journal's investigation revealed Figure duplication within Figure 1 and between Figure 1 and Figure 2. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/14188.

文章 "miR-375靶向sp1对结直肠癌细胞增殖的抑制作用 "由X.-H. Liu, J. Wang, Y.-H.Liu、J. Wang、Y.-H. Dong的文章发表在《Eur Rev Med Pharmacol Sci》2018;22 (22)Dong, 发表于《Eur Rev Med Pharmacol Sci 2018; 22 (2):405-411 - PMID: 29424897 已被主编撤回。在PubPeer(链接:https://pubpeer.com/publications/DF4072237DD0F624A7AE9B34B4EB6D)上提出一些疑虑后,主编已开始调查,以评估结果的有效性以及可能存在的数字操纵。起初,作者要求撤回此稿件,但在调查过程中无法发表进一步意见,因此未提供原始数据。期刊调查发现,图 1 内部以及图 1 和图 2 之间存在重复。因此,主编对所提交的结果不信任,决定撤稿。这篇文章已被撤回。https://www.europeanreview.org/article/14188。
{"title":"Retraction Note: The inhibitory effect of miR-375 targeting sp1 in colorectal cancer cell proliferation.","authors":"X-H Liu, J Wang, Y-H Dong","doi":"10.26355/eurrev_202410_36859","DOIUrl":"https://doi.org/10.26355/eurrev_202410_36859","url":null,"abstract":"<p><p>The article \"The inhibitory effect of miR-375 targeting sp1 in colorectal cancer cell proliferation\" by X.-H. Liu, J. Wang, Y.-H. Dong, published in Eur Rev Med Pharmacol Sci 2018; 22 (2): 405-411 - PMID: 29424897 has been retracted by the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/DF4072237DD0F624A7AE9B34B4EB6D), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. Initially, the authors asked to retract this manuscript, but were not available for further comments during the investigation; therefore, raw data were not provided. The journal's investigation revealed Figure duplication within Figure 1 and between Figure 1 and Figure 2. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/14188.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 20","pages":"4403"},"PeriodicalIF":3.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European review for medical and pharmacological sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1